Promotion of Mental Health in Adolescents: A School-Based Preventive Version of the Unified Protocol (UP-A Kind)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age11-18
SponsorUniversity of Coimbra
About this trial
The goal of this clinical trial is to assess the efficacy of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders for Adolescents (UP-A; Ehrenreich-May et al., 2018) as a universal school-based preventive intervention (UP-A Kind) in adolescents aged 11-18. This intervention aims to prevent emotional symptoms and improve adolescents' mental well-being in school setting, assessing changes in transdiagnostic processes. Researchers will compare an experimental group and a control group. Participants will participate in eight weekly sessions and will be assessed at 4 time points (pre- and post-treatment and 3-, 6- and 12-month follow-up). Control group participants will receive no intervention and will be assessed at the same time points.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Frequent 7º, 8º or 9º grade
Providing written informed assent (the adolescent and the legal tutor)
Being able to understand, write and read Portuguese
Disqualifiers
No exclusion criteria because of being a universal prevention study
Trial design
Design model
Parallel
Treatments tested in this trial
UP-A, a cognitive-behavioral structured group intervention, was adapted as a universal preventive intervention to be delivered in school settings (UP-A Kind).
BehavioralThe UP-A Kind is a school-based universal prevention intervention that aims to promote adaptive emotion regulations strategies, enhance mental well-being and prevent emotional disorders with the following contents: motivating to take care of mental well-being, psychoeducation about emotions, awareness of physical sensations, cognitive lexibility, behavioral experiences, recognizing warning signs, and promoting a compassionate attitude towards the self and others.
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: Experimental GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Socio-Demographic Information Questionnaire
Time frame
Baseline, Week 8, Follow-Up 3 Months, Follow-Up 6 Months and Follow-Up 12 Months2
Mental Health Continuum-Short Form (Keyes et al., 2008)
The scale was used to measure Positive Mental Health.
Time frame
Baseline, Week 8, Follow-Up 3 Months, Follow-Up 6 Months and Follow-Up 12 Months3
Kidscreen-10 (Portuguese version: Matos et al., 2012)
The scale was used to measure quality of life.
Time frame
Baseline, Week 8, Follow-Up 3 Months, Follow-Up 6 Months and Follow-Up 12 Months4
Overall Depression Severity and Impairment Scale (ODSIS) (Bentley, Gallagher, Carl, Barlow, 2014)
ODSIS was used to measure Depression and was translate and adapt to Portuguese for this study.
Time frame
Baseline, Week 8, Follow-Up 3 Months, Follow-Up 6 Months and Follow-Up 12 MonthsSecondary outcomes
1
Social Emotional Abilities Survey (UNICEF, 2023)
The scale was adapted and translated to Portuguese for this study.
Time frame
Baseline, Week 8, Follow-Up 3 Months, Follow-Up 6 Months and Follow-Up 12 Months2
The Multidimensional Emotional Disorder Inventory (MEDI) (Rosellini & Brown, 2019)
The scale was used to measure transdiagnostic dimensions of Emotional disorders.
Time frame
Baseline, Week 8, Follow-Up 3 Months, Follow-Up 6 Months and Follow-Up 12 Months3
Difficulties in Emotion Regulation Scale Short Form (DERS-SF) (Portuguese version: Moreira et al., 2020)
The scale was used to measure emotion regulation difficulties.
Time frame
Baseline, Week 8, Follow-Up 3 Months, Follow-Up 6 Months and Follow-Up 12 Months4
Emotional Avoidance Strategy Inventory for Adolescents (EASI-A) (Kennedy & Ehrenreich-May, 2016)
This measure is an adaptation of an adult measure of emotional avoidance (Fairholme, Ehrenreich-May, Ellard, Boisseau, Farchione, Barlow, 2008) and was adapted and translated to Portuguese for this study.
Time frame
Baseline, Week 8, Follow-Up 3 Months, Follow-Up 6 Months and Follow-Up 12 MonthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Coimbra
Lead sponsor
EPIS Association - Entrepreneurs for Social Inclusion
Collaborator
Z Zurich Foundation
Collaborator
Foundation for Science and Technology, Portugal
Collaborator
Source ClinicalTrials.gov